Charlotte Maxeke Johannesburg Academic Hospital

Johannesburg, Gauteng 2196

0 studies enrolling now · 11 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Cardiac Surgery, Disorder, Heart, Hemophilia, Hemophilia A, Hemophilia A or B, Hemophilia B, Postoperative, Prostate Cancer, Rheumatoid Arthritis

Studies at this site

• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors — Recruiting now
• Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery — Recruiting now
• Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major Surgery — Stopped early
• Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC — Running, not enrolling
• A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer — Running, not enrolling
• Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B — Completed
• A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors — Running, not enrolling
• PF-06741086 Long-term Treatment in Severe Hemophilia — Completed
• Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A — Stopped early
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). — Completed
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). — Completed